Population pharmacokinetics of polymyxin B in critically ill patients receiving continuous venovenous haemofiltration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Population pharmacokinetics of polymyxin B in critically ill patients receiving continuous venovenous haemofiltration

Published:2022-07 Issue:1 Volume:60 Page:106599
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Wang Peile,Xing Han,Zhang Fei,Liu Shaohua,Lu Yanqiu,Zhang Xiaojian,Yang Jing,Sun Tongwen

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference36 articles.

1. New agents for the treatment of infections with Gram-negative bacteria: restoring the miracle or false dawn?;Wright;Clin Microbiol Infect,2017

2. Pharmacology of polymyxins: new insights into an ‘old’ class of antibiotics;Velkov;Future Microbiol,2013

3. Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis;Sandri;J Antimicrob Chemother,2013

4. Polymyxin B and haemofiltration in an adolescent with leukaemia;Baird;J Antimicrob Chemother,2014

5. International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome of intravenous and inhaled polymyxin B treatment in patients with multidrug-resistant gram-negative bacterial pneumonia;International Journal of Antimicrobial Agents;2024-10

2. Efficacy and Safety Factors Related to Plasma Concentration-Optimized Polymyxin B Therapy in Treating Carbapenem-Resistant Gram-Negative Bacterial Infections in China;Infection and Drug Resistance;2024-07

3. How can polymyxin B be dosed based on current pharmacokinetic knowledge?;European Journal of Clinical Pharmacology;2024-06-07

4. A systematic evaluation of population pharmacokinetic models for polymyxin B in patients with liver and/or kidney dysfunction;Journal of Pharmacokinetics and Pharmacodynamics;2024-04-16

5. Pharmacokinetics of polymyxin B in different populations: a systematic review;European Journal of Clinical Pharmacology;2024-03-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3